K334m unaudited NPAT, up 18%, as @BSPPacific posted Q3 2026 earnings growth ahead of costs $BFL
stockwirex.com/asx-stocks/fi…
Immuron posted $2.2M sales in Q1 FY27 as Travelan outsold Imodium in pharmacy, per @ImmuronLtd $IMC
Visit stockwirex.com/asx-stock-new…
Perfect Stranger sales up 36.8% as Universal Store outlines FY27 YTD trading $UNI
stockwirex.com/asx-stock-new…
23 UK care homes to adopt @PainChek in Hallmark deal covering 1,800 licences $PCK
stockwirex.com/asx-stock-new…
9% sales lift to $2.2M in Q1 FY27 as @ImmuronLtd Travelan grows 14% in Australia $IMC
stockwirex.com/asx-stock-new…
$613m loan originations as @PlentiAU recorded first $600m quarter in 2Q27 $PLT
stockwirex.com/asx-stock-new…
$128m-$134m FY27 income guidance outlined for upward revision at @serkoonline 1H27 results $SKO
stockwirex.com/asx-stock-new…
Revenue up 6% to $32.8M as @experienceco_ recorded 20% EBITDA growth in Q1 FY27 $EXP
stockwirex.com/asx-stock-new…
$5.35 cash AVID proposal for Ingenia, up to $5.40 incl. distribution $INA
stockwirex.com/asx-stock-new…
No cash consideration as @InvexThera_ASX acquires Rekover for MS pivot, $10M placements $IXC
stockwirex.com/asx-stock-new…
$18.3m record revenue, up 14%, as @pureprofile_ir posted Q1 FY27 EBITDA up 27% $PPL
stockwirex.com/asx-stock-new…
Record $18.3m revenue and 27% EBITDA growth posted by @pureprofile_ir in Q1 FY27 $PPL
stockwirex.com/asx-stock-new…
US$2.6M Power by the Hour agreement with AATI for @orbitalcorpasx $OEC
stockwirex.com/asx-stock-new…
1.3M connections and $205M-$215M FY27 EBITDA guidance reaffirmed at @Aussie_BB AGM $ABB
stockwirex.com/asx-stock-new…
Profit up 26.5% to $4.2m as MaxiPARTS reported Q1 FY27 trading $MXI
stockwirex.com/asx-stock-new…
10MW AI data centre in Queensland, $250m project, agreement signed by @X2MConnect $X2M
stockwirex.com/asx-stock-new…
TTV up 18.0% to $4.6b as Zip posted Q1 FY27 results, reconfirming FY27 guidance $ZIP
stockwirex.com/asx-stock-new…
$50M received and $265M in escrow as Energy World confirms turbine delivery $EWC
stockwirex.com/asx-stock-new…
A$4.78M non-dilutive R&D tax rebate received by Amplia, funding narmafotinib trials $ATX
stockwirex.com/asx-stock-new…
